Decken K, Köhler G, Palmer-Lehmann K, Wunderlin A, Mattner F, Magram J, Gately M K, Alber G
Department of Infectious Diseases, F. Hoffmann-La Roche AG, Basel, Switzerland.
Infect Immun. 1998 Oct;66(10):4994-5000. doi: 10.1128/IAI.66.10.4994-5000.1998.
To analyze the roles of interleukin-12 (IL-12) and the IL-12-dependent Th1 response in resistance to Cryptococcus neoformans, we have established a chronic infection model in wild-type mice and in mice with targeted disruptions of the genes for the IL-12p35 and IL-12p40 subunits (IL-12p35(-/-) and IL-12p40(-/-) mice, respectively) as well as in mice with a targeted disruption of the IL-4 gene. Long-term application of exogenous IL-12 prevented death of infected wild-type mice for the entire period of the experiment (up to 180 days) but did not resolve the infection. Infected IL-12p35(-/-) and IL-12p40(-/-) mice died significantly earlier than infected wild-type mice, whereas infection of IL-4-deficient mice led to prolonged survival. Interestingly, infected IL-12p40(-/-) mice died earlier and developed higher organ burdens than IL-12p35(-/-) mice, which, for the first time in an infection model, suggests a protective role of the IL-12p40 subunit independent of the IL-12 heterodimer. The fungal organ burdens of IL-4-deficient mice and IL-12-treated wild-type mice were significantly reduced compared to those of untreated wild-type mice and IL-12-deficient mice. Histopathological analysis revealed reduction of the number of granulomatous lesions following treatment with IL-12. Susceptibility of both IL-12p35(-/-) and IL-12p40(-/-) mice was associated with marginal production of gamma interferon and elevated levels of IL-4 from CD4(+) T cells, which indicates Th2 polarization in the absence of IL-12, whereas wild-type mice developed a Th1 response. Taken together, our data emphasize the essential role of IL-12 for protective Th1 responses against C. neoformans.
为分析白细胞介素-12(IL-12)及依赖IL-12的Th1反应在抵抗新型隐球菌中的作用,我们在野生型小鼠、IL-12p35和IL-12p40亚基基因靶向敲除的小鼠(分别为IL-12p35(-/-)和IL-12p40(-/-)小鼠)以及IL-4基因靶向敲除的小鼠中建立了慢性感染模型。在整个实验期间(长达180天),长期应用外源性IL-12可防止感染的野生型小鼠死亡,但无法清除感染。感染的IL-12p35(-/-)和IL-12p40(-/-)小鼠比感染的野生型小鼠死亡明显更早,而IL-4缺陷小鼠感染后存活时间延长。有趣的是,感染的IL-12p40(-/-)小鼠比IL-12p35(-/-)小鼠死亡更早且器官负荷更高,这在感染模型中首次表明IL-12p40亚基独立于IL-12异二聚体具有保护作用。与未处理的野生型小鼠和IL-12缺陷小鼠相比,IL-4缺陷小鼠和经IL-12处理的野生型小鼠的真菌器官负荷显著降低。组织病理学分析显示,用IL-12治疗后肉芽肿病变数量减少。IL-12p35(-/-)和IL-12p40(-/-)小鼠的易感性与γ干扰素产生减少及CD4(+)T细胞IL-4水平升高有关,这表明在缺乏IL-12时出现Th2极化,而野生型小鼠产生Th1反应。综上所述,我们的数据强调了IL-12在针对新型隐球菌的保护性Th1反应中的重要作用。